a biopharmaceutical company, which focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs.
Industry Biotechnology
A.I.dvisor tells us that EDSA and SNPX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDSA and SNPX's prices will move in lockstep.
Ticker / NAME | Correlation To EDSA | 1D Price Change % | ||
---|---|---|---|---|
EDSA | 100% | +0.46% | ||
SNPX - EDSA | 33% Poorly correlated | +10.00% | ||
ORMP - EDSA | 32% Poorly correlated | -1.74% | ||
RNAZ - EDSA | 31% Poorly correlated | +2.50% | ||
XBIO - EDSA | 29% Poorly correlated | +2.31% | ||
PGEN - EDSA | 29% Poorly correlated | +5.17% | ||
More |